A1 Refereed original research article in a scientific journal

Generation and characterisation of scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac applications




AuthorsMajid Qasim A., Ghimire Bishwa R., Merkely Bela, Randi Anna M., Harding Sian E., Talman Virpi, Földes Gabor

PublisherSpringer

Publication year2024

JournalAngiogenesis

Journal name in sourceAngiogenesis

Journal acronymAngiogenesis

Volume27

Issue3

First page 561

Last page582

ISSN0969-6970

eISSN1573-7209

DOIhttps://doi.org/10.1007/s10456-024-09929-5

Web address https://doi.org/10.1007/s10456-024-09929-5

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/421370031


Abstract
Coronary microvascular disease (CMD) and its progression towards major adverse coronary events pose a significant health challenge. Accurate in vitro investigation of CMD requires a robust cell model that faithfully represents the cells within the cardiac microvasculature. Human pluripotent stem cell-derived endothelial cells (hPSC-ECs) offer great potential; however, they are traditionally derived via differentiation protocols that are not readily scalable and are not specified towards the microvasculature. Here, we report the development and comprehensive characterisation of a scalable 3D protocol enabling the generation of phenotypically stable cardiac hPSC-microvascular-like ECs (hPSC-CMVECs) and cardiac pericyte-like cells. These were derived by growing vascular organoids within 3D stirred tank bioreactors and subjecting the emerging 3D hPSC-ECs to high-concentration VEGF-A treatment (3DV). Not only did this promote phenotypic stability of the 3DV hPSC-ECs; single cell-RNA sequencing (scRNA-seq) revealed the pronounced expression of cardiac endothelial- and microvascular-associated genes. Further, the generated mural cells attained from the vascular organoid exhibited markers characteristic of cardiac pericytes. Thus, we present a suitable cell model for investigating the cardiac microvasculature as well as the endothelial-dependent and -independent mechanisms of CMD. Moreover, owing to their phenotypic stability, cardiac specificity, and high angiogenic potential, the cells described within would also be well suited for cardiac tissue engineering applications.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
The research was funded by the British Heart Foundation (RE/13/4/30184 and RM/17/1/33377), the Medical Research Council neg 10.1007/s10456-024-09929-5 10.1007/s10456-024-09929-5 (MR/R025002/1), the Research Council of Finland (projects 321564; 353109; 328909), the Finnish Foundation for Cardiovascular Research, Sigrid Jus?lius Foundation, and the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Therapeutic Development thematic programme of the Semmelweis University, the Hungarian National Research, Development and Innovation Fund (RRF-2.3.1-21-2022-00003, TKP2021-EGA-23, NKFIH 146125). Open access funding provided by Semmelweis University.


Last updated on 2024-28-11 at 12:02